Finance

Beta
Lists
SKYE:NASDAQ
Skye Bioscience Inc
$0.70
-1.24%
(-0.0088) 1D
Jun 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
$0.70
High
$0.72
Low
$0.68
Mkt. cap
24.56M
Avg. vol.
179.96K
Volume
194.12K
52-wk high
$5.75
52-wk low
$0.57
EPS
-$1.45
Beta
2.95
Shares outstanding
35.14M
No. of employees
2
Open
$0.70
High
$0.72
Low
$0.68
Mkt. cap
24.56M
Avg. vol.
179.96K
Volume
194.12K
52-wk high
$5.75
52-wk low
$0.57
EPS
-$1.45
Beta
2.95
Shares outstanding
35.14M
No. of employees
2
News stories
From sources across the web
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
SectorBiotechnology
Websiteskyebioscience.com
Analyst Ratings
Based on 3 analysts giving stock ratings to SKYE in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SKYE in the last 3 months.
Highest
Current $0.70
$20.00 (+2,757.14%)
Average
$13.00 (+1,757.14%)
Lowest
$6.00 (+757.14%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$20.00
+2,757.1%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$6.00
+757.1%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
$10.00
+1,328.6%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
$2.00
+185.7%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.34M
9.36M
11.47M
7.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.91M
3.91M
3.43M
4.74M
Operating expense
18.24M
13.26M
14.90M
12.67M
Total operating expenses
18.24M
13.26M
14.90M
12.67M
Operating income
-18.24M
-13.26M
-14.90M
-12.67M
Other non operating income
-
-
-502.00
-2.41K
EBT including unusual items
-17.62M
-12.75M
-14.44M
-12.51M
EBT excluding unusual items
-17.71M
-12.85M
-14.62M
-12.51M
Income tax expense
3.40K
-
-
-
Effective tax rate
-0.02%
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.62M
-12.75M
-14.44M
-12.51M
Net profit margin
-
-
-
-
Earnings per share
-0.45
-0.32
-0.37
-0.32
Interest and investment income
533.09K
418.47K
274.10K
169.62K
Interest expense
-
-
-
-2.20K
Net interest expenses
533.09K
418.47K
274.10K
167.42K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.06M
-13.09M
-14.72M
-12.50M
Gain or loss from assets sale
-89.36K
-91.40K
-179.99K
7.62K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer